Keros Therapeutics, Inc.

KROS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001664710

SEC filings (opens in a new tab)

In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Keros Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of KROS: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	161	4	156	−1
Shares	36.7M	89.7K	36.7M	+81.7K (+0.2%)
Value	$582.1M	$1.42M	$428.6M	−$152.0M (−26.2%)

4 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (49)

Institutions that held Keros Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to KROS in Q1 2025
Institution	Shares	Value	% of portfolio
Nuveen, LLC	3,947,455	$94.5M	0.03%
Logos Global Management LP	2,000,000	$20.4M	3.62%
Tang Capital Management LLC	1,100,000	$11.2M	0.62%
DRW Securities, LLC	464,895	$4.74M	0.40%
Rangeley Capital, LLC	408,234	$4.16M	4.76%
PDT Partners, LLC	276,060	$2.81M	0.20%
Ikarian Capital, LLC	274,009	$2.79M	0.91%
Qube Research & Technologies Ltd	273,342	$2.79M	0.00%
22NW, LP	179,000	$1.82M	1.22%
RBF Capital, LLC	170,014	$1.73M	0.11%
Acadian Asset Management LLC	147,567	$1.50M	0.00%
Western Standard LLC	134,914	$1.37M	0.81%
Jump Financial, LLC	103,826	$1.06M	0.02%
Stonepine Capital Management, LLC	100,000	$1.02M	1.18%
Centiva Capital, LP	90,000	$917.1K	0.05%
Monimus Capital Management, LP	84,055	$856.5K	0.73%
Boothbay Fund Management, LLC	81,270	$828.1K	0.03%
XTX Topco Ltd	48,121	$490.4K	0.03%
Squarepoint Ops LLC	43,984	$448.2K	0.00%
Tejara Capital Ltd	40,245	$410.1K	0.20%
Man Group plc	34,013	$346.6K	0.00%
SummitTX Capital, L.P.	30,884	$314.7K	0.01%
Quadrature Capital Ltd	28,871	$293.0K	0.01%
Quinn Opportunity Partners LLC	25,000	$254.8K	0.02%
HAP Trading, LLC	22,551	$229.8K	0.08%
AQR Capital Management LLC	22,136	$225.6K	0.00%
ExodusPoint Capital Management, LP	18,976	$193.0K	0.00%
Shay Capital LLC	18,832	$191.9K	0.06%
Corton Capital Inc.	18,212	$185.6K	0.61%
Creative Planning	17,278	$176.1K	0.00%
Schonfeld Strategic Advisors LLC	15,558	$158.5K	0.00%
HRT Financial LP	14,747	$150.0K	0.00%
Dark Forest Capital Management LP	13,015	$132.6K	0.01%
Entropy Technologies, LP	11,891	$121.2K	0.01%
Profund Advisors LLC	11,569	$117.9K	0.01%
Polymer Capital Management (US) LLC	11,541	$117.6K	0.04%
Virtus Investment Advisers, Inc.	8,907	$90.8K	0.02%
Aquatic Capital Management LLC	6,775	$69.0K	0.00%
FNY Investment Advisers, LLC	2,500	$25.0K	0.02%
Versant Capital Management, Inc	643	$6.55K	0.00%
Allworth Financial LP	370	$5.34K	0.00%
Coldstream Capital Management Inc	522	$5.32K	0.00%
The PNC Financial Services Group, Inc.	107	$1.09K	0.00%
Private Wealth Management Group, LLC	102	$1.04K	0.00%
Parkside Financial Bank & Trust	55	$558	0.00%
WPG Advisers, LLC	24	$245	0.00%
EverSource Wealth Advisors, LLC	10	$102	0.00%
True Wealth Design, LLC	3	$31	0.00%
Capital Advisors, Ltd. LLC	16	$0	0.00%

Sold out (50)

Institutions that held Keros Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of KROS in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Braidwell LP	1,894,439	$30.0M
Darwin Global Management, Ltd.	1,687,135	$26.7M
Holocene Advisors, LP	1,199,990	$19.0M
Jefferies Financial Group Inc.	866,737	$13.7M
Mangrove Partners	736,385	$11.7M
TCG Crossover Management, LLC	550,000	$8.71M
Lynx1 Capital Management LP	544,001	$8.61M
Integral Health Asset Management, LLC	450,000	$7.12M
Eventide Asset Management, LLC	380,000	$6.02M
American Century Companies Inc	328,920	$5.21M
Boxer Capital Management, LLC	250,000	$3.96M
Emerald Advisers, LLC	244,633	$3.87M
Balyasny Asset Management LLC	221,391	$3.50M
Avidity Partners Management LP	210,000	$3.32M
Altium Capital Management LP	175,000	$2.77M
Emerald Mutual Fund Advisers Trust	155,347	$2.46M
Occudo Quantitative Strategies LP	103,408	$1.64M
Sofinnova Investments, Inc.	95,375	$1.51M
Y-Intercept (Hong Kong) Ltd	74,255	$1.18M
Norges Bank	64,900	$1.03M
UBS Asset Management Americas Inc	64,416	$1.02M
Diadema Partners LP	63,547	$1.01M
Swiss National Bank	59,000	$934.0K
TD Asset Management Inc	51,600	$816.8K
Fred Alger Management, LLC	48,481	$767.5K
State of Wisconsin Investment Board	44,434	$703.4K
NEOS Investment Management LLC	35,663	$564.5K
Tema ETFs LLC	35,663	$564.5K
Voya Investment Management LLC	29,488	$466.8K
Bryce Point Capital, LLC	28,127	$445.3K
Readystate Asset Management LP	25,523	$404.0K
SG Americas Securities, LLC	24,493	$388.0K
F/M Investments LLC	17,061	$270.1K
Janus Henderson Group PLC	14,307	$226.3K
Wellington Management Group LLP	14,033	$222.1K
EntryPoint Capital, LLC	11,535	$182.6K
Gsa Capital Partners LLP	11,158	$177.0K
ProShare Advisors LLC	10,549	$167.0K
Point72 (DIFC) Ltd	9,078	$143.7K
Zurcher Kantonalbank (Zurich Cantonalbank)	7,449	$117.9K
Great West Life Assurance Co	7,371	$116.0K
KLP Kapitalforvaltning AS	5,700	$90.2K
Virtus ETF Advisers LLC	3,857	$61.1K
KBC Group NV	1,622	$26.0K
Ensign Peak Advisors, Inc	340	$5.38K
Massmutual Trust Co FSB	78	$1.24K
Advisor Group Holdings, Inc.	20	$317
J.Safra Asset Management Corp	8	$125
IFP Advisors, Inc	1	$16
Farther Finance Advisors, LLC	1	$16

Not filed for Q1 2025 yet (4)

Institutions that held Keros Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KROS in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	79,485	$1.26M
EDBI Pte Ltd	10,105	$160.0K
Cassady Schiller Wealth Management, LLC	75	$1.19K
Global Retirement Partners, LLC	13	$206